BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18214795)

  • 1. The genetics of Adamantiades-Behcet's disease.
    Durrani K; Papaliodis GN
    Semin Ophthalmol; 2008; 23(1):73-9. PubMed ID: 18214795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent findings on the genetics of Behçet's disease].
    Hüe-Lemoine S; Amoura Z; Wechsler B; Piette JC; Caillat-Zucman S
    Ann Med Interne (Paris); 1999 Oct; 150(6):499-503. PubMed ID: 10615536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease.
    Mizuki N; Ota M; Katsuyama Y; Yabuki K; Ando H; Goto K; Nakamura S; Bahram S; Ohno S; Inoko H
    Arthritis Rheum; 1999 Sep; 42(9):1961-6. PubMed ID: 10513813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of MICA alleles and HLA-B51 in Italian patients with Behçet's disease.
    Salvarani C; Boiardi L; Mantovani V; Olivieri I; Ciancio G; Cantini F; Salvi F; Malatesta R; Molinotti C; Govoni M; Trotta F; Filippini D; Paolazzi G; Viggiani M
    J Rheumatol; 2001 Aug; 28(8):1867-70. PubMed ID: 11508592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic studies of Behçet's disease.
    Mizuki N; Ohno S
    Rev Rhum Engl Ed; 1996; 63(7-8):520-7. PubMed ID: 8896070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease.
    Soto-Vega E; García-Muñoz R; Richaud-Patin Y; Zúñiga-Ramos J; Crispín JC; Díaz-Jouanen E; Flores-Suárez LF; Llorente L; Granados J
    Immunol Lett; 2004 May; 93(2-3):211-5. PubMed ID: 15158619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular involvement is associated with HLA-B51 in Adamantiades-Behçet's disease.
    Krause L; Köhler AK; Altenburg A; Papoutsis N; Zouboulis CC; Pleyer U; Stroux A; Foerster MH
    Eye (Lond); 2009 May; 23(5):1182-6. PubMed ID: 18551141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on Behçet's disease.
    Kalayciyan A; Zouboulis C
    J Eur Acad Dermatol Venereol; 2007 Jan; 21(1):1-10. PubMed ID: 17207160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic gene responsible for the predisposition of Behçet's disease.
    Mizuki N; Inoko H; Ohno S
    Int Rev Immunol; 1997; 14(1):33-48. PubMed ID: 9203025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behçet's disease: an update on the pathogenesis.
    Gül A
    Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S6-12. PubMed ID: 11760403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial Behçet's disease.
    Akpolat T; Koç Y; Yeniay I; Akpek G; Güllü I; Kansu E; Kiraz S; Ersoy F; Batman F; Kansu T
    Eur J Med; 1992 Nov; 1(7):391-5. PubMed ID: 1341477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations.
    Mizuki N; Ota M; Yabuki K; Katsuyama Y; Ando H; Palimeris GD; Kaklamani E; Accorinti M; Pivetti-Pezzi P; Ohno S; Inoko H
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3702-8. PubMed ID: 11053265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to find a B51 IEF variant associated with Behçet's disease.
    Baricordi OR; Melchiorri L; Balboni A; Perrone S; Pivetti-Pezzi P; Sensi A
    Dis Markers; 1988; 6(4):275-7. PubMed ID: 3233883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece.
    Yabuki K; Mizuki N; Ota M; Katsuyama Y; Palimeris G; Stavropoulos C; Koumantaki Y; Spyropoulou M; Giziaki E; Kaklamani V; Kaklamani E; Inoko H; Ohno S
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):1921-6. PubMed ID: 10440244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspective on Behçet's disease.
    Sakane T
    Int Rev Immunol; 1997; 14(1):89-96. PubMed ID: 9203029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The novel -G646A polymorphism of the TNFalpha promoter is associated with the HLA-B51 allele in Korean patients with Behçet's disease.
    Chang HK; Jang WC; Park SB; Nam YH; Lee SS; Park YW; Kim SK
    Scand J Rheumatol; 2007; 36(3):216-21. PubMed ID: 17657677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet's disease.
    Takemoto Y; Naruse T; Namba K; Kitaichi N; Ota M; Shindo Y; Mizuki N; Gul A; Madanat W; Chams H; Davatchi F; Inoko H; Ohno S; Kimura A
    Tissue Antigens; 2008 Oct; 72(4):347-53. PubMed ID: 18700875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behçet's disease (Adamantiades-Behçet's disease).
    Kaneko F; Togashi A; Saito S; Sakuma H; Oyama N; Nakamura K; Yokota K; Oguma K
    Clin Dev Immunol; 2011; 2011():681956. PubMed ID: 21052488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole-genome screening for susceptibility genes in multicase families with Behçet's disease.
    Karasneh J; Gül A; Ollier WE; Silman AJ; Worthington J
    Arthritis Rheum; 2005 Jun; 52(6):1836-42. PubMed ID: 15934084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of Adamantiades-Behçet's disease.
    Zouboulis CC; May T
    Med Microbiol Immunol; 2003 Aug; 192(3):149-55. PubMed ID: 12684757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.